Yazar "Yeşilbalkan Ö.U." seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Aromatherapy: The effect of lavender on anxiety and sleep quality in patients treated with chemotherapy(Oncology Nursing Society, 2018) Özkaraman A.; Dügüm Ö.; Yılmaz H.Ö.; Yeşilbalkan Ö.U.BACKGROUND: A cancer diagnosis is a serious stressor that is associated with anxiety, depression, sleep disorders, and inability to fulfill daily routines. Many pharmacologic and nonpharmacologic options are available to help patients with cancer manage anxiety. OBJECTIVES: This randomized, controlled trial examined the effects of lavender oil aromatherapy on anxiety and sleep quality in patients undergoing chemotherapy. METHODS: 70 patients were randomly assigned to a lavender oil group, a tea tree oil group, and a control group with no oil. A patient identification form, the State-Trait Anxiety Inventory, and the Pittsburgh Quality Sleep Index (PSQI) were used to measure anxiety and sleep quality before and after chemotherapy. FINDINGS: State anxiety before and after chemotherapy did not vary among groups. The authors compared trait anxiety values before and after chemotherapy and found a significant difference in the lavender group. In addition, a significant change in PSQI measurements before and after chemotherapy was observed. © 2018, Oncology Nursing Society. All rights reserved.Öğe The Relationship Between Social Support From Family and Quality of Life Among Cancer Patients: A CrossSectional Study(Guilan University of Medical Sciences, 2020) Toygar I.; Yeşilbalkan Ö.U.; Kürkütlü M.; Tuğba A.G.Introduction: Improving the Quality of Life (QoL) is considered one of the main objectives in the care of cancer patients. Achieving this objective, it is essential to determine the factors affecting QoL in cancer patients. The studies in the literature have determined the effects of various factors on QoL but social support from family has remained to be studied. Objective: The present study aimed to determine the relationship between perceived social support from family and QoL in cancer patients. Materials and Methods: This cross-sectional study was conducted in an oncology unit of a university hospital in İzmir City, Turkey, from March to October 2019. A convenience sample of 276 cancer patients participated in the study. A patient identification form, the Perceived Social Support from family scale (PSS-Family), and the Quality of Life indexcancer version (QLI-C) were used for data collection. The scores of PSS-Family and QLI-C ranged 0-20 and 66-396, respectively. Regression analysis was used to estimate the effect of perceived social support from family on QoL. Results: Of the participants, 65.2% were female. The Mean±SD age of the study sample was 47.5±14.4 years. Also, the Mean±SD scores of PSS-Family and QLI-C were 16.43±3.01 and 307.77±27.48, respectively. Regression analysis revealed that perceived social support from family was associated with a relative increase in QoL index (B=3.44, P=0.001, R2=0.141). Conclusion: Perceived social support from family is positively associated with QoL in cancer patients. Nurses should consider this relationship when they plan to improve the QoL of cancer patients. © 2020. All Rights Reserved.Öğe Reliability and validity of the turkish version of the dialysis symptom index in chronic hemodialysis patients(2013) Önsöz H.B.; Yeşilbalkan Ö.U.OBJECTIVE: This study was planned for the purpose of adapting and determining the reliability and validity of the Turkish version of the "Dialysis Symptom Index (DSI)" for Turkish hemodialysis patients. MATERIAL and Methods: This study was conducted in two dialysis units. A total of 120 hemodialysis patients participated in the research. Written permission to conduct the research was obtained from the institutions and the patients. Research data were collected using a questionnaire and the DSI. It assesses symptoms and their severity and is widely used in patients in the end stage of the disease. The kappa values were calculated for test-retest and the Cronbach alpha coefficients were also calculated in the reliability study. Language validity and content validity were tested in the validity study. Results : The patients' mean age was 54.53 (13.80). The kappa values ranged between 0.10 to 0.9 on the DSI. Cronbach's alpha coefficient of the DSI was determined to be 0.83. Conclusion: As a result of this study carried out in accordance with methodological research principles, the Turkish version of the DSI has been understood to be a reliable and valid measurement index in Turkish populations.Öğe Validity and reliability of the Edmonton Symptom Assessment Scale in Turkish cancer patients(2008) Yeşilbalkan Ö.U.; Özkütük N.; Karadakovan A.; Turgut T.; Kazgan B.The Edmonton Symptom Assessment Scale (ESAS) is simple and easy to use with cancer patients. This study was planned for the purpose of adapting and determining the validity and reliability of the ESAS for Turkish culture. The study was conducted in outpatient and inpatient chemotherapy units at a university hospital between December 2004 and February 2005. A total of 113 cancer patients participated in the research. Written permission to conduct the research was obtained from the facility and verbal and written consent was obtained from the patients. Research data were collected using a questionnaire, the ESAS and the Rotterdam Symptom Checklist (RSC). In the ESAS validity study, language validity, content validity and criterion-related validity were tested. In the reliability study Cronbach's alpha and item-total score correlation were calculated. The patients' mean age was 48.86±13.18. The Pearson product moment correlation coefficient between the ESAS and RSC scores was calculated to be r=0.75, p < 0.05. A Cronbach's alpha coefficient of 0.77 was determined for the ESAS. The lowest item-total correlation on the ESAS (r=0.30, p <0.05) was for item 10 (other, constipation) and the highest (r=0.62, p <0.05) was for item 1 (pain). The Turkish version of the ESAS was determined to be a valid and reliable tool for use in Turkish individuals with cancer.
